Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 113   

Articles published

JNJ 101.08 +0.62 (0.62%)
price chart
Johnson & Johnson Hikes Quarterly Dividend 7 Percent
Johnson & Johnson on Thursday said it's raising its quarterly dividend by 7 percent, marking its 53rd straight year of dividend increases.
Johnson & Johnson Lifts Dividend  Wall Street Journal
After Dividend Hike at J&J, Investors Can Expect Many Years of More Hikes  24/7 Wall St.
Johnson & Johnson Trends Favor Four Stocks
Johnson & Johnson commented that it saw another quarter of utilization improvement (albeit slight), which marked the third consecutive quarter of positive utilization trends (surgical procedures, hospital admissions and physician office visits).
Johnson & Johnson Looks to Expand in Asia
With 2014 revenue of $74 billion and net profit of $16 billion, Johnson & Johnson JNJ 0.03 % is among the world's largest health-care companies.
Johnson & Johnson And Finicky Share Prices (JNJ)
On April 23rd of 2015, Johnson & Johnson (NYSE:JNJ) announced a 7.1% dividend increase, moving its quarterly payout from $0.70 to $0.75 per share.
Johnson & Johnson (JNJ) to Issue Quarterly Dividend of $0.75  The Legacy
Strong Dollar Remains Headache For Johnson & Johnson
The continued climb of the U.S. dollar weighed heavily on pharmaceutical giant Johnson & Johnson's Johnson & Johnson's first quarter earnings reported Tuesday morning. It was in many ways a repeat of a quarter earlier - only this time the numbers were ...
J&J earnings beat despite THIS factor  CNBC
Johnson & Johnson Reports 2015 First-Quarter Results:  MarketWatch
Durex owner Reckitt Benckiser barred from buying Johnson & Johnson's KY
The Commerce Commission has declined an application from Reckitt Benckiser Group, owners of Durex, to purchase Johnson & Johnson's K-Y brand and product assets. The Commission banned the deal from going ahead because it was not satisfied it ...
Commerce Commission declines lubricant merger  Scoop.co.nz (press release)
Johnson & Johnson: An Excellent 3% Dividend Choice For Risk-Averse Income ...
Income investors on the lookout for stable, reliable dividend payers have to look no further than Johnson & Johnson (NYSE:JNJ) to have their investment needs met.
Johnson & Johnson's (NYSE:JNJ) Earnings Raise Concerns  ETF Daily News
Johnson & Johnson - Healthy profits  Nasdaq
3 Long-Tail Growth Drivers for Johnson & Johnson
Johnson & Johnson isn't your traditional pharmaceutical company -- it's actually a healthcare conglomerate comprised of a consumer healthcare products division, a global medical devices segment, and of course its gigantic pharmaceutical segment.
Johnson & Johnson Reveals Plans To Expand Into Asia  Bidness ETC
Johnson & Johnson (NYSE:JNJ) To Expand In Asia  USMarketsDaily (blog)
Google teams with Johnson & Johnson to improve robot surgeon vision
Johnson & Johnson's Ethicon division has decades of experience in surgical tool development, but has only been in the robotic surgery space for a short period of time, Knewitz noted.
Google, Johnson & Johnson to partner on surgical robot technology  Apple Insider
Google is working with Johnson & Johnson on medical robots  Daily Mail
Johnson & Johnson Posts Earnings, Lowers EPS Guidance on April 14
Johnson & Johnson (JNJ) posted its 1Q15 earnings on April 14, 2015. The company beat Wall Street EPS (earnings per share) estimates of $1.53 marginally, posting $1.56 EPS.